{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "Amino-acid-based compositions, suitable in therapy for the healing of wounds and lesions, in particular for application in the ophthalmic field, comprising: proline, glycine and lysine, up to 80 wt % on the total of all the amino acids or active ingredients envisaged; one or more of the amino acids selected in the group comprising leucine, isoleucine and threonine, in an overall quantity of between 2 wt % and 60 wt % on the total of all the amino acids or active ingredients envisaged. Preferably envisaged are also other essential amino acids, in particular methionine, phenyl alanine, histidine, tryptophan, and non-essential amino acids, in particular tyrosine and cyst(e)ine (i.e., cystine and cysteine). Other amino acids can be added, provided that their sum is a percentage lower than 20 wt % with respect to the sum of the other active ingredients, and less than 10 wt % for each individual amino acid.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E401070-T1: [Translated] COMPOSITIONS CONTAINING AMINO ACIDS, SUITABLE FOR WOUND HEALING, IN PARTICULAR FOR THE TREATMENT OF THE EYE on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401070-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/pjaa-2r75", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/pjaa-2r75", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E401070-T1: [Translated] COMPOSITIONS CONTAINING AMINO ACIDS, SUITABLE FOR WOUND HEALING, IN PARTICULAR FOR THE TREATMENT OF THE EYE"}